Caricamento...
The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis
Safer and more effective oral drugs are required to treat visceral leishmaniasis, a parasitic disease that kills 50-60,000 people each year. Here we report that fexinidazole, a drug currently in phase I clinical trials for treating African trypanosomiasis, shows promise for treating visceral leishma...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3457684/ https://ncbi.nlm.nih.gov/pubmed/22301556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3003326 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|